| 000 | 01776 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515151156.0 | ||
| 264 | 0 | _c20090130 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a0956-4624 | ||
| 024 | 7 |
_a10.1258/ijsa.2008.008075 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSued, O | |
| 245 | 0 | 0 |
_aUse of darunavir and enfuvirtide in a pregnant woman. _h[electronic resource] |
| 260 |
_bInternational journal of STD & AIDS _cDec 2008 |
||
| 300 |
_a866-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aDarunavir |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Viral |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEnfuvirtide |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp41 _xadministration & dosage |
| 650 | 0 | 4 |
_aHIV Fusion Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aPeptide Fragments _xadministration & dosage |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aLattner, J | |
| 700 | 1 | _aGun, A | |
| 700 | 1 | _aPatterson, P | |
| 700 | 1 | _aAbusamra, L | |
| 700 | 1 | _aCesar, C | |
| 700 | 1 | _aFink, V | |
| 700 | 1 | _aKrolewiecki, A | |
| 700 | 1 | _aCahn, P | |
| 773 | 0 |
_tInternational journal of STD & AIDS _gvol. 19 _gno. 12 _gp. 866-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1258/ijsa.2008.008075 _zAvailable from publisher's website |
| 999 |
_c18504779 _d18504779 |
||